Track topics on Twitter Track topics that are important to you
The third time may be the charm for Framingham, Mass.-based Alzheon when it comes to an initial public offering – because the company has balked the first two times it attempted to go public on the ...
Alzheimer's biotech Alzheon sets terms for $35 million IPO $ALZH $IPO #IPO http://dlvr.it/QlKTLg
Alzheon, Inc., is a clinical-stage biotechnology company focused on brain health, memory and aging, developing innovative treatments for Alzheimerâs disease and other neurode...
Alzheon, Inc. is committed to developing innovative medicines for patients suffering from Alzheimerâs disease and other neurological and psychiatric disorders. Our lead clini...
We have published hundreds of Alzheon, Inc. news stories on BioPortfolio along with dozens of Alzheon, Inc. Clinical Trials and PubMed Articles about Alzheon, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alzheon, Inc. Companies in our database. You can also find out about relevant Alzheon, Inc. Drugs and Medications on this site too.
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase 'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...